IFNB1 and pachyonychia congenita: Interestingly, the group of patients defined as moderate with fibrosis (n = 8 out of 29) and severe without fibrosis (n = 4 out of 23) presented fibrosis-like symptoms or not, independently of IFN-β levels, implying other yet unidentified blood biomarker/s for PC patients.